Stay updated on Valaciclovir in Early Alzheimer's: Clinical Trial
Sign up to get notified when there's something new on the Valaciclovir in Early Alzheimer's: Clinical Trial page.

Latest updates to the Valaciclovir in Early Alzheimer's: Clinical Trial page
- Check6 days agoChange DetectedThe VALZ-Pilot record now displays details of the valaciclovir study for people with early Alzheimer’s disease, including its design, participant criteria, treatment plan, study locations, and measured outcomes.SummaryDifference49%

- Check13 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.2 to v3.8.0; the study record remains unavailable behind a 403 Forbidden page.SummaryDifference0.2%

- Check27 days agoChange DetectedA sitewide NIH banner announces a transition to using “Super Intelligence” instead of “Artificial Intelligence.” The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check34 days agoChange DetectedThe footer’s site revision identifier was updated from v3.7.0 to v3.7.1 while the page continued to show a 403 error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study content, indicating access is blocked. The visible content displays a 403 header and a Home link, replacing the full study record details that were previously visible.SummaryDifference18%

- Check62 days agoChange DetectedThe page shows Revision: v3.7.0, replacing the previous Revision: v3.6.6. This indicates a small update to the page version rather than substantive changes to the study details.SummaryDifference0.1%

Stay in the know with updates to Valaciclovir in Early Alzheimer's: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Valaciclovir in Early Alzheimer's: Clinical Trial page.